Cagrilintide is a long-acting amylin analog studied in relation to amylin receptor signaling, while GLP-1 (SG) is a GLP-1 receptor agonist analog. Pairing them in one vial allows both receptor pathways to be examined together in laboratory models.
Cagrilintide is a long-acting amylin analog studied in relation to amylin receptor signaling, while GLP-1 (SG) is a GLP-1 receptor agonist analog. Pairing them in one vial allows both receptor pathways to be examined together in laboratory models.